A Phase 2, Double-Blind, Placebo Controlled Trial to Assess the Efficacy of Quetiapine Fumarate Extended Release for the Treatment of Alcohol Dependence in Very Heavy Drinkers.
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2016
At a glance
- Drugs Quetiapine (Primary)
- Indications Alcohol withdrawal
- Focus Therapeutic Use
- 01 Nov 2016 Results (n=218) assessing safety of liver injury published in the Clinical Drug Investigation.
- 01 Apr 2014 New trial record